Clinical trials: Sinus Pain
Cancer
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
This is a phase III, randomized, double-blind, placebo-controlled, multicenter study of the clinical response to fentanyl sublingual spray as a treatment for breakthrough cancer pain.
- Trial name
- NCT00538850
- Testing
- Fentanyl sublingual spray
- Where
- United States
- Volunteers
- 130 people
- Sponsor
- INSYS Therapeutics Inc
Sinus Pain, Congestion
ClearUP Longitudinal Pilot Study
Single arm, open label pilot study assessing the longitudinal home use of ClearUp Sinus Pain Relief for four weeks.
- Trial name
- NCT03888274
- Testing
- ClearUP Sinus Pain Relief
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Tivic Health Systems